Cathrine Ørskov

Cathrine Ørskov

Head of Department


  1. 1992
  2. Published

    Glucagon-like peptide-1, a new hormone of the enteroinsular axis

    Ørskov, Cathrine, 1992, In: Diabetologia. 35, p. 701-711

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Lack of effect of synthetic human gastric inhibitory polypeptide and glucagon-like peptide 1 [7-36 amide] infused at near-physiological concentrations on pentagastrin-stimulated gastric acid secretion in normal human subjects

    Nauck, M. A., Bartels, Emil Daniel, Ørskov, Cathrine, Ebert, R. & Creutzfeldt, W., 1992, In: Digestion. 52, 3-4, p. 214-21 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Somatostatin is an essential paracrine link in acid inhibition of gastrin secretion

    Holst, Jens Juul, Ørskov, Cathrine & Poulsen, S. S., 1992, In: Digestion. 51, p. 95-102

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Glucagon-like peptide-1, a new hormone of the entero-insular axis

    Ørskov, Cathrine, Aug 1992, In: Diabetologia. 35, 8, p. 701-11 11 p.

    Research output: Contribution to journalReviewResearchpeer-review

  6. Published

    Vagal control of the release of somatostatin, vasoactive intestinal polypeptide, gastrin-releasing peptide, and HCl from porcine non-antral stomach

    Holst, Jens Juul, Skak-Nielsen, T., Ørskov, Cathrine & Seier-Poulsen, S., Aug 1992, In: Scandinavian Journal of Gastroenterology. 27, 8, p. 677-85 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. 1993
  8. Published

    Biological effects and metabolic rates of GLP-1 7-36 amide and GLP-1 7-37 in healthy volunteers are indistinguishable

    Ørskov, Cathrine, Wettergren, A. & Holst, Jens Juul, 1993, In: Diabetes. 42, p. 658-661

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired and diabetic glucose tolerance

    Laang, S., Thorsteinsson, B., Røder, M. E., Ørskov, Cathrine, Holst, Jens Juul, Nerup, J. & Koch, C., 1993, In: Acta Endoctrinologica. 128, p. 207-214

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Pres. incretin effect of imm. gastric inhibotory polyp. (GIP) and glucagon-like pept. (GLP-1) after oral glucose in type 1 diab. pat. with end-stage nepr. treated by comb. heter. pancreas a. kidn.tra.

    Nauck, M., Büsing, M., Ørskov, Cathrine, Siegel, E. B., Talartschik, J., Baartz, A., Baartz, T., Hopt, U. T., Ebert, R., Becker, H. & Creutzfeldt, W., 1993, In: Acta Diabetologica. 30, p. 36-45

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations

    Nauck, M. A., Bartels, Emil Daniel, Ørskov, Cathrine, Ebert, R. & Creutzfeldt, W., Apr 1993, In: Endocrinology. 76, 4, p. 912-7 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. Published

    Biological effects and metabolic rates of glucagonlike peptide-1 7-36 amide and glucagonlike peptide-1 7-37 in healthy subjects are indistinguishable

    Ørskov, Cathrine, Wettergren, A. & Holst, Jens Juul, May 1993, In: Diabetes. 42, 5, p. 658-61 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 4 5 6 7 8 ...12 Next

ID: 137086045